Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H28N4O6.ClH |
Molecular Weight | 504.963 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC(=N)C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N3CCC(CC3)OCC(O)=O
InChI
InChIKey=YUWYXULCUNUQCG-BDQAORGHSA-N
InChI=1S/C24H28N4O6.ClH/c25-22(26)16-3-5-17(6-4-16)23(32)27-20(13-15-1-7-18(29)8-2-15)24(33)28-11-9-19(10-12-28)34-14-21(30)31;/h1-8,19-20,29H,9-14H2,(H3,25,26)(H,27,32)(H,30,31);1H/t20-;/m0./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C24H28N4O6 |
Molecular Weight | 468.5023 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
LAMIFIBAN is a potent and selective nonpeptide glycoprotein IIb/IIIa antagonist. It inhibits platelet aggregation and thrombus formation by preventing the binding of fibrinogen to platelets. It was in clinical development as an injectable antithrombotic agent for treating and preventing acute coronary syndromes but showed no significant effects on clinical outcomes.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093869 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8759635 |
1.4 nM [IC50] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:03:53 GMT 2023
by
admin
on
Fri Dec 15 16:03:53 GMT 2023
|
Record UNII |
3UZ1CTQ989
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1327
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80947247
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
PRIMARY | |||
|
MM-37
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL108111
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
PRIMARY | |||
|
C81568
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
PRIMARY | |||
|
3UZ1CTQ989
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
PRIMARY | |||
|
3038483
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
PRIMARY | |||
|
243835-65-6
Created by
admin on Fri Dec 15 16:03:53 GMT 2023 , Edited by admin on Fri Dec 15 16:03:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |